Hemagen Diagnostics, Inc.
HMGN · OTC
9/30/2012 | 6/30/2012 | 3/31/2012 | 12/31/2011 | |
|---|---|---|---|---|
| Market Cap | $0 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $5 | $5 | $5 | $5 |
| Enterprise Value | $5 | $6 | $5 | $5 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | -7.6% | -14.7% | 0.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 45.9% | 47.8% | 31.5% | 36.8% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -0.7% | 2.9% | -7.6% | -19.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -18.6% | -13.9% | -21.9% | -33.3% |
| EPS Diluted | -0.011 | -0.01 | -0.02 | -0.02 |
| % Growth | -5% | 50% | 0% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |